Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Lazaro Gamio / Axios

One of the first decisions Rush Holt made at the helm of American Association for the Advancement of Science earlier this year was to officially support the March for Science in Washington. It was delicate ground for the non-partisan organization but Holt maintained it was about defending the scientific process, not taking a political stand.

Holt, who spent 16 years in Congress as a Democrat representing central New Jersey before becoming CEO of AAAS, chatted with Axios last week about how science is bumping up against politics today.

Here are the highlights:

Science is: a way of asking questions so that they can be answered empirically and verifiably. I think it's that simple.

That's something, by the way, that we're losing. The appreciation of it and the ability to do it has been eroding in our society. It's one of the things that has been really dominant in our advocacy recently — to try to restore what I call the reverence for evidence.

On the absence of a science advisor: I wish I could get the new administration to see that they would be well-served by having scientists scattered throughout their agencies. Next month's crisis, or the crisis the month after that — which will surely come — your ability to deal with them will be improved if you have scientists there to offer advice or comments in all of the agencies. Not just a science advisor in the White House sitting on the National Security Council, but also people in the Department of Transportation and the Department of Housing and Urban Development. It's people who get it about science.

There are dozens of positions in the administration that are designated to be explicitly for science experts. I think fewer than a dozen are filled now. That's a problem. You would think that the President and people around him would want to be prepared to deal with the crises that come up, because if you wait to collect information after the crisis is occurring, it's a little late.

This is a good time for science but…federal investment in research is the lowest it's been since Sputnik. The appreciation of evidence by the ordinary person is, I think, the lowest it's been in my lifetime. That's really troubling. If the work of a small number of people is more and more productive, but society at large has a poorer and poorer understanding of what science is and how it is relevant to them, then that doesn't bode well for the future of science.

It is this interesting contradiction and conundrum. We have this reasonably great opportunity with burgeoning research findings, but this is counterbalanced by policies that are more grounded in ideology than evidence and by a greater number of clueless people who are distrustful of science.

The politics problem: Should science avoid being politicized? Absolutely. Even with my simple definition, embedded in some of those simple words is the idea that science necessarily structures the questions and the gathering of evidence in the best way to exclude bias — of your instruments and experimental design, but also personal bias and wishful thinking — all of those things that can contaminate the evidence. You don't want to inject ideology or wishful thinking or party platforms into the collection and the analysis of evidence.

Scientists commit the logical fallacy that the converse is true. If the process of science — this precious, valuable, extraordinary thing — is challenged, then scientists should speak up. Scientists should go into the public square if they can shed light on an issue of importance or if the scientific process is challenged.

America the empirical: Our country was founded with a very scientific outlook. Some of the founders themselves were actual scientists — Thomas Jefferson and Benjamin Rush, but also Thomas Paine. People don't know he wrote a tract on swamp gas. John Adams studied astronomy at Harvard. They not only were scientists, but they had very much a scientific perspective. In the Federalist Papers arguing for the ratification of the Constitution, the word "experiment" appears far more often than the word "democracy."

Evidence is for everyone: It's important for civic education and social education, but it also means that people who are not professional scientists can still ask questions that can be answered empirically. I would like to get to the point where every citizen, every day, asks their political leaders and policymakers, "What's the evidence?"

Go deeper

Updated 26 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: Trump received COVID vaccine at White House in January — CDC director warns "now is not the time" to lift COVID restrictions.
  2. Education: More schools are reopening in the U.S.
  3. Vaccine: J&J CEO "absolutely" confident in vaccine distribution goals Most states aren't prioritizing prisons for COVID vaccines — Vaccine hesitancy is shrinking.
  4. Economy: Apple says all U.S. stores open for the first time since start of pandemic — What's really going on with the labor market.
  5. Sports: Poll weighs impact of athlete vaccination.
  6. World: Latin America turns to China and Russia for COVID-19 vaccines.
Dave Lawler, author of World
45 mins ago - World

Latin America turns to China and Russia for COVID-19 vaccines

Several countries in the Americas have received their first vaccine shipments over the past few weeks — not from the regional superpower or from Western pharmaceutical giants, but from China, Russia, and in some cases India.

Why it matters: North and South America have been battered by the pandemic and recorded several of the world’s highest death tolls. Few countries other than the U.S. have the capacity to manufacture vaccines at scale, and most lack the resources to buy their way to the front of the line for imports. That’s led to a scramble for whatever supply is available.

More schools are reopening in the U.S.

Students settle into a classroom in New York City. Photo: Michael Loccisano/Getty Images

More than 72% of K-12 students are now attending schools that offer in-person or hybrid models of learning.

The big picture: The U.S. is seeing an almost-universal return of schools that were in-person as of November, as well as a gradual return in parts of the country that had been virtual for almost a year.